Suppr超能文献

从新冠疫情期间到疫情后恢复正常状态,成年人维生素D状况的变化。

Changes in vitamin D status among adults from the COVID-19 pandemic to post-pandemic normality.

作者信息

Chen Yanzhao, Kong Guilian

机构信息

Demonstration Laboratory of Quality Control for in vitro Analysis, Department of Nuclear Medicine, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, The Clinical Medical College of Provincial Hospital of Zhengzhou University, Zhengzhou, Henan, China.

出版信息

Front Nutr. 2024 Aug 2;11:1407890. doi: 10.3389/fnut.2024.1407890. eCollection 2024.

Abstract

INTRODUCTION

The COVID-19 pandemic has prompted widespread lockdown measures globally, significantly impacting daily activities and outdoor exposure. This study investigates the effect of the pandemic on vitamin D levels and the prevalence of vitamin D deficiency in the adult population, with a focus on gender-specific differences.

METHODS

A total of 1525 adults from Henan Provincial People's Hospital were included. Serum 25-hydroxyvitamin D (25(OH)D) levels were measured using the Elecsys® Vitamin D total kit on the Roche Cobas® 8000 analyzer. The Clinical Application Consensus on Vitamin D and Its Analogs defined deficiency as 25(OH)D levels below 20 ng/ml. Statistical analysis was performed using SPSS 23.0 and GraphPad Prism 8 software.

RESULTS

The overall 25(OH)D levels increased from 18.14 ng/ml [IQR: 13.78, 23.68] in 2022 to 19.15 ng/ml [IQR: 14.88, 25.01] in 2023 (=0.004). Males exhibited significant improvement in 25(OH)D levels from 18.01 ng/ml [IQR: 14.10, 23.53] in 2022 to 20.49 ng/ml [IQR: 16.11, 26.01] in 2023 (<0.001). The prevalence of vitamin D deficiency decreased from 62% in 2022 to 54.9% in 2023 (=0.009), with a notable reduction in males (64.1% in 2022 to 47.2% in 2023). Among 168 individuals tested in both years, 25(OH)D levels increased from 20.73 ± 9.37 ng/ml in 2022 to 22.28 ± 8.59 ng/ml in 2023 (=0.012), and the deficiency rate decreased from 58.3% in 2022 to 47.0% in 2023 (=0.038). The 40-49 age group showed significant improvement in 25(OH)D levels from 16.10 ng/ml [IQR: 12.41, 21.18] in 2022 to 18.28 ng/ml [IQR: 13.91, 23.86] in 2023 (=0.005), with a reduction in deficiency rate from 72.8% to 59.9% (=0.02). Furthermore, in February, March, and April, 2022, 25(OH)D levels were significantly lower compared to 2023 (<0.001, =0.002, <0.001, respectively), accompanied by a higher prevalence of vitamin D deficiency (<0.001, =0.015, <0.001, respectively).

DISCUSSION

This study demonstrates that the COVID-19 pandemic significantly impacted vitamin D levels, leading to an increased prevalence of deficiency, particularly among males. These findings highlight the critical importance of maintaining sufficient outdoor activities to ensure adequate vitamin D levels. The data underscore the need for public health strategies to address potential deficiencies during prolonged periods of limited outdoor exposure.

摘要

引言

新冠疫情在全球范围内促使广泛实施封锁措施,对日常活动和户外暴露产生了重大影响。本研究调查了疫情对成年人群维生素D水平及维生素D缺乏症患病率的影响,并重点关注性别差异。

方法

纳入了河南省人民医院的1525名成年人。使用罗氏Cobas® 8000分析仪上的Elecsys®维生素D总检测试剂盒测量血清25-羟基维生素D(25(OH)D)水平。维生素D及其类似物的临床应用共识将缺乏定义为25(OH)D水平低于20 ng/ml。使用SPSS 23.0和GraphPad Prism 8软件进行统计分析。

结果

总体25(OH)D水平从2022年的18.14 ng/ml [四分位间距(IQR):13.78,23.68] 升至2023年的19.15 ng/ml [IQR:14.88,25.01](P = 0.004)。男性的25(OH)D水平从2022年的18.01 ng/ml [IQR:14.10,23.53] 显著提高至2023年的20.49 ng/ml [IQR:16.11,26.01](P < 0.001)。维生素D缺乏症的患病率从2022年的62%降至2023年的54.9%(P = 0.009),男性患病率显著降低(从2022年的64.1%降至2023年的47.2%)。在两年均接受检测的168名个体中,25(OH)D水平从2022年的20.73 ± 9.37 ng/ml升至2023年的22.28 ± 8.59 ng/ml(P = 0.012),缺乏率从2022年的58.3%降至2023年的47.0%(P = 0.038)。40 - 49岁年龄组的25(OH)D水平从2022年的16.10 ng/ml [IQR:12.41,21.18]显著提高至2023年的18.28 ng/ml [IQR:13.91,23.86](P = 0.005),缺乏率从72.8%降至59.9%(P = 0.02)。此外,在2022年2月、3月和4月,25(OH)D水平显著低于2023年(分别为P < 0.001、P = 0.002、P < 0.001),同时维生素D缺乏症的患病率更高(分别为P < 0.001、P = 0.015、P < 0.001)。

讨论

本研究表明,新冠疫情对维生素D水平产生了重大影响,导致缺乏症患病率上升,尤其是在男性中。这些发现凸显了保持足够户外活动以确保充足维生素D水平的至关重要性。数据强调了在户外暴露受限的长期期间制定公共卫生策略以解决潜在缺乏问题的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07a1/11327124/4c5bc0530ef3/fnut-11-1407890-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验